| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 6396 |
| 1 | PREDNISONE | 5089 |
| 2 | ERGOCALCIFEROL | 4852 |
| 3 | ADALIMUMAB | 4846 |
| 4 | ASPIRIN | 4613 |
| 5 | ASPIRIN 81 MG | 4439 |
| 6 | ASPIRIN 325 MG | 4435 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 3960 |
| 8 | OMEPRAZOLE MAGNESIUM | 3673 |
| 9 | ACETAMINOPHEN 500MG | 3604 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESCHERICHIA COLI | 222 | 0.5536 |
| 1 | ORITAVANCIN DIPHOSPHATE | 92 | 0.3098 |
| 2 | INFLIXIMAB-DYYB | 691 | 0.2005 |
| 3 | SOYBEAN OIL | 134 | 0.1971 |
| 4 | ERGOCALCIFEROL | 4852 | 0.1632 |
| 5 | POTASSIUM IODIDE | 228 | 0.1528 |
| 6 | TRISODIUM CITRATE DIHYDRATE | 756 | 0.1102 |
| 7 | OFATUMUMAB | 3506 | 0.1042 |
| 8 | I. V. FAT EMULSION | 75 | 0.1032 |
| 9 | HUMAN IMMUNOGLOBULIN G | 2114 | 0.1010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12042 |
| 1 | Corticosteroid [EPC] | 11565 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 7343 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 6592 |
| 4 | Benzodiazepine [EPC] | 5955 |
| 5 | Provitamin D2 Compound [EPC] | 4855 |
| 6 | Proton Pump Inhibitor [EPC] | 4782 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 4767 |
| 8 | Vitamin C [EPC] | 4391 |
| 9 | Interferon beta [EPC] | 3784 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 324 | 0.4709 |
| 1 | Provitamin D2 Compound [EPC] | 4855 | 0.1632 |
| 2 | Human Immunoglobulin G [EPC] | 2913 | 0.1383 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 761 | 0.1300 |
| 4 | Bispecific HER2-directed Antibody [EPC] | 9 | 0.1098 |
| 5 | Lipid Emulsion [EPC] | 270 | 0.1022 |
| 6 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 59 | 0.0980 |
| 7 | Autologous Cellular Immunotherapy [EPC] | 531 | 0.0914 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 160 | 0.0771 |
| 9 | Endoglycosidase [EPC] | 140 | 0.0756 |